Nano-X Imaging (NNOX) Shares Outstanding (Weighted Average) (2019 - 2025)
Nano-X Imaging (NNOX) reported Shares Outstanding (Weighted Average) of $2.1 million for Q4 2025, down 51.9% on a YoY basis from $4.5 million in Q4 2024, and up 3231.35% quarter-over-quarter from $64324.0 in Q3 2025.
Nano-X Imaging (NNOX) Shares Outstanding (Weighted Average) (2019 - 2025) Analysis & Trends
Nano-X Imaging has reported Shares Outstanding (Weighted Average) for 7 years, with the latest figure at $2.1 million in Q4 2025.
- For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) fell 51.9% year-over-year to $2.1 million; the trailing twelve-month figure through Dec 2025 stood at $2.1 million (down 51.9% YoY), and the FY2025 full-year result was $2.1 million, down 51.9% from the prior year.
- Shares Outstanding (Weighted Average) for Q4 2025 stood at $2.1 million, up from $64324.0 in the prior quarter.
- The five-year high for Shares Outstanding (Weighted Average) was $52.2 million in Q4 2022, with the low at $150.0 in Q1 2021.
- Historically, Shares Outstanding (Weighted Average) has averaged $3.1 million across 5 years, with a median of $57148.0 in 2023.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) jumped 108235.41% — and 2023, when it sank 99.89%.
- Nano-X Imaging's Shares Outstanding (Weighted Average) stood at $48216.0 in 2021, then jumped by 108235.41% to $52.2 million in 2022, then slumped by 99.89% to $56368.0 in 2023, then soared by 7803.95% to $4.5 million in 2024, then tumbled by 51.9% to $2.1 million in 2025.
- The last three Shares Outstanding (Weighted Average) figures came in at $2.1 million (Q4 2025), $64324.0 (Q3 2025), and $63910.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Nano-X Imaging | 3.62 Mn | -55.99 Mn | -3.62 Mn | 2.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.14 Mn |
| Sep 30, 2025 | 64,324.00 |
| Jun 30, 2025 | 63,910.00 |
| Mar 31, 2025 | 63,946.00 |
| Dec 31, 2024 | 4.46 Mn |
| Sep 30, 2024 | 58,624.00 |
| Jun 30, 2024 | 58,005.00 |
| Mar 31, 2024 | 57,901.00 |
| Dec 31, 2023 | 56,368.00 |
| Sep 30, 2023 | 57,148.00 |
| Jun 30, 2023 | 55,375.00 |
| Mar 31, 2023 | 55,157.00 |
| Dec 31, 2022 | 52.24 Mn |
| Sep 30, 2022 | 52,276.00 |
| Jun 30, 2022 | 52,192.00 |
| Mar 31, 2022 | 52,124.00 |
| Dec 31, 2021 | 48,216.00 |
| Sep 30, 2021 | 47,851.00 |
| Mar 31, 2021 | 150.00 |
| Dec 31, 2020 | 35,654.00 |